Literature DB >> 28088734

In vivo and in silico sedative-hypnotic like activity of 7-methyljuglone isolated from Diospyros lotus L.

Abdur Rauf1, Sengul Uysal2, Taibi Ben Hadda3, Ghias Uddin4, Muhammad Asif Nawaz5, Haroon Khan6, Bina S Siddiqui7, Muslim Raza8, Saud Bawazeer9, Gokhan Zengin2.   

Abstract

Diospyros lotus L. possesses different therapeutic activities such as antioxidant, anti-proliferative, anti-microbial and sedative. However, no studies on the sedative-hypnotic activity of 7-methyljuglone are reported. In the present study, we have evaluated in vivo the anxiolytic-hypnotic like effects of 7-methyljuglone in mice with open field and phenobarbitone-induced sleeping time tests. We have also assessed in silico the involvement of GABAA, GABAB and 5HT1 neurotransmission in its mechanism of action. The intraperitoneal administration of 7-methyljuglone (2.5-10mg/kg) reduce significantly the number of crossed lines in mice open field test and concomitantly it shown a significant activity in term of onset of sleeping time and also in its duration. Moreover, 7-methyljuglone demonstrated in silico an interesting interaction with GABAA but not GABAB and 5HT1binding sites. All of these results, taken together, 7-methyljuglone may be an innovative candidate for designing new pharmaceutical and therapeutic applications.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  7-methyljuglone; Diospyros lotus L.; Docking study; Gaba; Medicinal plants; Sedative-hypnotic activity

Mesh:

Substances:

Year:  2017        PMID: 28088734     DOI: 10.1016/j.biopha.2017.01.021

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  In Vivo Anti-inflammatory, Analgesic, and Sedative Studies of the Extract and Naphthoquinone Isolated from Diospyros kaki (Persimmon).

Authors:  Saud Bawazeer; Abdur Rauf
Journal:  ACS Omega       Date:  2021-04-01

Review 2.  Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.

Authors:  Hammad Ullah; Haroon Khan
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.